CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 681669-681922 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"T15488","span":{"begin":0,"end":253},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Fexofenadine, a non-sedating, selective H1-receptor antagonist, is currently indicated for use in children aged 6-11 years with seasonal allergic rhinitis in a number of countries, including the US, and has an excellent safety profile in this age group."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T45","span":{"begin":0,"end":253},"obj":"Sentence"}],"text":"Fexofenadine, a non-sedating, selective H1-receptor antagonist, is currently indicated for use in children aged 6-11 years with seasonal allergic rhinitis in a number of countries, including the US, and has an excellent safety profile in this age group."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T6283","span":{"begin":128,"end":154},"obj":"Disease"},{"id":"T6285","span":{"begin":137,"end":145},"obj":"Disease"},{"id":"T6286","span":{"begin":146,"end":154},"obj":"Disease"}],"attributes":[{"id":"A6283","pred":"mondo_id","subj":"T6283","obj":"http://purl.obolibrary.org/obo/MONDO_0005324"},{"id":"A6284","pred":"mondo_id","subj":"T6283","obj":"http://purl.obolibrary.org/obo/MONDO_0011786"},{"id":"A6285","pred":"mondo_id","subj":"T6285","obj":"http://purl.obolibrary.org/obo/MONDO_0004980"},{"id":"A6286","pred":"mondo_id","subj":"T6286","obj":"http://purl.obolibrary.org/obo/MONDO_0003014"}],"text":"Fexofenadine, a non-sedating, selective H1-receptor antagonist, is currently indicated for use in children aged 6-11 years with seasonal allergic rhinitis in a number of countries, including the US, and has an excellent safety profile in this age group."}

    CORD-19-PD-HP

    {"project":"CORD-19-PD-HP","denotations":[{"id":"T3392","span":{"begin":137,"end":154},"obj":"Phenotype"}],"attributes":[{"id":"A3392","pred":"hp_id","subj":"T3392","obj":"http://purl.obolibrary.org/obo/HP_0003193"}],"text":"Fexofenadine, a non-sedating, selective H1-receptor antagonist, is currently indicated for use in children aged 6-11 years with seasonal allergic rhinitis in a number of countries, including the US, and has an excellent safety profile in this age group."}